Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys

Transplantation

Volumn 59, Issue 2, 1995, Pages 256-262

  Kawai, Tatsuo ^a   Benedict Cosimi, A ^a   Colvin, Robert B ^b   Powelson, John ^a   Eason, James ^a   Kozlowski, Tomacsz ^b   Sykes, Megan ^b   Monroy, Rod ^c   Tanaka, Mayumi ^b   Sachs, David H ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BioTransplant Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; MONOCLONAL ANTIBODY; THYMOCYTE ANTIBODY;

ALLOGENEIC RESTRICTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CHIMERA; CONTROLLED STUDY; DRUG BLOOD LEVEL; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MIXED LYMPHOCYTE CULTURE; MONKEY; NONHUMAN; PRIORITY JOURNAL; WHOLE BODY RADIATION;

ANIMAL; ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; ANTILYMPHOCYTE SERUM; BONE MARROW TRANSPLANTATION; COMPARATIVE STUDY; GRAFT SURVIVAL; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; MACACA FASCICULARIS; MALE; SUPPORT, U.S. GOV'T, P.H.S.; TRANSPLANTATION CHIMERA; WHOLE-BODY IRRADIATION;

EID: 0028860210     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199501000-00018     Document Type: Article

References (18)

1. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allo geneic or xenogeneic bone marrow leads to specific acceptance of allografts or xeno-grafts. Nature 1984; 307: 168.
2. Cobbold SP, Martin G, Qin S, Waldman H. Monoclonal antibod ies to promote marrow engraftment and tissue graft tolerance. Nature 1986; 323: 164.
3. Smith CV, Suzuki T, Guzzetta PC, et al. Bone marrow trans plantation in miniature swine: IV. Development of myeloabla-tive regimens that allow engraftment across major histocom patibility barriers. Transplantation 1993; 56: 541.
4. Raaf J, Bryan C, Monden M, et al. Bone marrow and renal transplantation in canine recipients prepared by total lymphoid irradiation. Transplant Proc 1981; 13: 429.
5. Myburgh JA, Smit JA, Hill RRH, Browde S. Transplantation tolerance in primates following total lymphoid irradiation and allogeneic bone marrow injection. Transplantation 1980; 29: 405.
6. Gottlieb M, Strober S, Hoppe RT, et al. Engraftment of alloge neic bone marrow without graft-verus-host disease in mongrel dogs using total lymphoid irradiation. Transplantation 1980; 29: 487.
7. Cardis DT, Liegeois A, Barrett I, Monaco AP. Enhanced survival of canine renal allografts of ALS-treated dogs given bone marrow. Transplant Proc 1973; 5: 671.
8. Wood ML, Monaco AP. Models of specific unresponsiveness to tissue antilymphcyte serum treated mice. Transplant Proc 1978; 10: 379.
9. Thomas JM, Carver FM, Cunningham PRG, et al. Kidney al lograft tolerance in primates without chronic immuno suppression-the role of veto cells. Transplantation 1991; 51: 198.
10. Thomas JM, Carver FM, Kasten-Jolly J, et al. Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism. Transplantation 1994; 57: 101.
11. Barber WH, Mankin JA, Laskow DA, et al. Long-term results of a controlled prospective study with transfusion of donor specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation 1991; 51: 70.
12. Rolles K, Burroughs AK, Davidson BR, et al. Donor specific bone marrow infusion after orthotopic liver transplantation. Lancet 1994; 343: 263.
13. Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med 1989; 169: 493.
14. Kawai T, Wong J, MacLean MDJ, et al. Immunosuppressive efficacy of a murine mAb (6G12) specific for the cynomolgus monkey CD3 antigen. Transplant Proc (in press).
15. Cosimi AB, Delmonico FL, Wright JK, et al. Prolonged survival of nonhuman primate renal allograft recipients treated only with anti-CD4 monoclonal antibody. Surgery 1990; 108: 406.
16. Tomita Y, Sachs DH, Sykes M. Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow. Blood 1994; 83: 939.
17. Dallman MJ, Shiho O, Page Th, et al. Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway. J Exp Med 1991; 173: 79.
18. Starzl TE, Demetris AJ, Murase N, et al. Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today 1993; 14: 326.